ABJ879 agent, and epothilones, 83–85 absorption, computational modeling of, 380–384 ABT-450 inhibitor, and HCV PIs, 250 ACH-1625 inhibitor, and HCV PIs, 250 actinomycins, and non-ansamycin antibiotics, 3–5 advanced hematological malignancies, and macrocyclic kinase inhibitors, 197–198 aminopyrimidi...